Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Injection With Prostate Brachytherapy
NCT00681148Phase 2Withdrawn
- Sponsor
- Emory University
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in lower urinary tract symptoms (LUTS) (2 arms), sponsored by Emory University. Primary endpoint: Urinary symptoms (AUA Symptoms scores) at 12 months. Status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT00681148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681148.